Regulator of G-protein signaling 5 (5-13)

Regulator of G-protein signaling 5

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: ta-395

Synonyms/Alias:Regulator of G-protein signaling 5 (5-13)

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
Sequence
LAALPHSCL
Areas of Interest
Antigen-presenting Cells; Cancer Research

Regulator of G-protein signaling 5 (5-13) is a synthetic peptide fragment derived from the C-terminal region of the RGS5 protein, a key member of the regulator of G-protein signaling (RGS) family. This peptide comprises amino acids 5 through 13 of RGS5, a protein known for its involvement in modulating G-protein-coupled receptor (GPCR) signaling pathways by accelerating the GTPase activity of Gα subunits. By mimicking a specific segment of the native protein, this fragment enables researchers to dissect the functional domains of RGS5, facilitating detailed studies of its role in cellular signaling networks. The biochemical properties of this peptide make it a valuable tool for probing protein-protein interactions, elucidating regulatory mechanisms in GPCR signaling, and supporting the development of molecular probes for signal transduction research.

Signal transduction studies: As a representative segment of the RGS5 protein, this peptide fragment is widely used to investigate the molecular mechanisms underlying GPCR-mediated signal transduction. Researchers employ it to map the structural regions responsible for G-protein interaction and to assess the impact of specific amino acid sequences on the modulation of GTPase activity. By introducing the peptide into in vitro assays or cell-based systems, it becomes possible to delineate the contribution of the 5-13 region to overall RGS5 function, offering insights into how this domain influences downstream signaling cascades.

Protein interaction mapping: The 5-13 peptide serves as a practical probe for characterizing protein-protein interactions involving RGS5. By acting as a competitive inhibitor or binding partner in affinity-based assays, it enables the identification of cellular proteins that specifically recognize or interact with the C-terminal segment of RGS5. This approach aids in uncovering novel binding partners, deciphering interaction motifs, and understanding the specificity of RGS5-mediated regulatory events within complex signaling networks.

Peptide structure-function analysis: Researchers utilize this synthetic fragment to perform structure-activity relationship (SAR) studies, which are critical for elucidating the functional determinants within the RGS5 sequence. By systematically modifying the peptide or comparing its activity to other fragments, scientists can pinpoint key residues responsible for biological activity. These investigations provide a foundation for rational design of peptide-based modulators or inhibitors targeting RGS5-related pathways, advancing the understanding of sequence-function relationships in regulatory proteins.

Assay development: The defined sequence and biochemical stability of the 5-13 peptide make it suitable for use as a standard or control in the development of bioanalytical assays targeting RGS5 or related signaling molecules. It can be incorporated into binding, enzymatic, or immunodetection assays to calibrate responses, validate assay specificity, or optimize experimental conditions. Such applications are essential for ensuring the accuracy and reproducibility of high-throughput screening platforms or mechanistic studies involving RGS proteins.

Peptide synthesis research: As a short, well-characterized peptide, the 5-13 fragment offers a model system for optimizing synthetic strategies and evaluating peptide modification techniques. Researchers in peptide chemistry may use it to test coupling reagents, assess purity profiles, or explore post-synthetic modifications such as labeling or cyclization. The reliable synthesis and characterization of this fragment support methodological advances in solid-phase peptide synthesis and analytical peptide science, contributing to broader efforts in peptide-based research and development.

Source#
Homo sapiens (human)
Epitope
5-13
Restricting HLA
HLA-A2
References
Boss; Clin Cancer Res 2007

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Synthesis ServicescGMP Peptide ServiceEpitope Mapping ServicesPeptide CDMOPeptide Analysis ServicesPeptide Nucleic Acids SynthesisPeptide Modification ServicesCustom Conjugation Service
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers